Palladium-catalyzed asymmetric alkylation in the synthesis of cyclopentanoid and cycloheptanoid core structures bearing all-carbon quaternary stereocenters
Abstract
General catalytic asymmetric routes toward cyclopentanoid and cycloheptanoid core structures embedded in numerous natural products have been developed. The central stereoselective transformation in our divergent strategies is the enantioselective decarboxylative alkylation of seven-membered β-ketoesters to form α-quaternary vinylogous esters. Recognition of the unusual reactivity of β-hydroxyketones resulting from the addition of hydride or organometallic reagents enabled divergent access to y-quaternary acylcyclopentenes through a ring contraction pathway or y-quaternary cycloheptenones through a carbonyl transposition pathway. Synthetic applications of these compounds were explored through the preparation of mono-, bi-, and tricyclic derivatives that can serve as valuable intermediates for the total synthesis of complex natural products. This work complements our previous work with cyclohexanoid systems.
Additional Information
© 2011 Elsevier Ltd. Received 7 September 2011. Received in revised form 7 October 2011. Accepted 10 October 2011. Available online 19 October 2011. This publication is based on work supported by Award No. KUS-11-006-02, made by King Abdullah University of Science and Technology (KAUST). The authors wish to thank NIH-NIGMS (R01M080269-01), Amgen, Abbott, Boehringer Ingelheim, and Caltech for financial support. A.Y.H. thanks Roche for an Excellence in Chemistry Award and Abbott for an Abbott Scholars Symposium Award. M.R.K. acknowledges Eli Lilly for a predoctoral fellowship. T.J. thanks the Danish Council for Independent Research/Natural Sciences for a postdoctoral fellowship. Materia, Inc. is gratefully acknowledged for the donation of metathesis catalysts. Lawrence Henling and Dr. Michael Day are acknowledged for X-ray crystallographic structure determination. The Bruker KAPPA APEXII X-ray diffractometer used in this study was purchased via an NSF CRIF:MU award to Caltech (CHE-0639094). Prof. Sarah Reisman, Dr. Scott Virgil, Dr. Christopher Henry, and Dr. Nathaniel Sherden contributed with helpful discussions. Dr. David VanderVelde and Dr. Scott Ross are acknowledged for NMR assistance. The Varian 400 MR instrument used in this study was purchased via an NIH award to Caltech (NIH RR027690). Dr. Mona Shahgholi and Naseem Torian are acknowledged for high-resolution mass spectrometry assistance.Attached Files
Accepted Version - nihms-332928.pdf
Supplemental Material - mmc1.pdf
Files
Name | Size | Download all |
---|---|---|
md5:6a4510b16c24f6423704e44924112457
|
4.2 MB | Preview Download |
md5:f33717d06ea3ea23a385f25a855f03dc
|
12.3 MB | Preview Download |
Additional details
- PMCID
- PMC3279929
- Eprint ID
- 28938
- Resolver ID
- CaltechAUTHORS:20120124-111234894
- King Abdullah University of Science and Technology (KAUST)
- KUS-11-006-02
- NIH
- R01GM080269-01
- Amgen
- Abbott
- Boehringer-Ingelheim
- Caltech
- Danish Council for Independent Research-Natural Sciences
- Materia, Inc.
- NSF
- CHE-0639094
- NIH
- RR027690
- Created
-
2012-01-24Created from EPrint's datestamp field
- Updated
-
2021-11-09Created from EPrint's last_modified field